Increased NFκ-B Activity in HCT116 Colorectal Cancer Cell Line Harboring TLR4 Asp299Gly Variant
Abstract
Toll-Like Receptor 4 (TLR4), considered one of the most important TLR, recognizes lipopolysaccharide of gram-negative bacteria. Recognition of ligands by TLRs induces signaling pathways resulting in activation of transcriptional factors such as NF-κB which are involved in the expression of inflammatory cytokines and chemokines. To prevent an inappropriate immune response, a complex network of molecules negatively regulates TLRs and their associated signaling pathways.
Two cosegregating single nucleotide polymorphisms of the human TLR4 gene, namely Asp299Gly and Thr399Ile, have been associated with hyporesponsiveness to inhaled LPS. The purpose of this study was to determine the impact of TLR4 gene variant on NF-κB activity in colorectal cancer cell line. HCT116 cells were transfected with wild-type and mutants Flag-CMV1-TLR4 expression vectors. Western blot analysis was performed to evaluate selected molecules involved in TLR4 signaling. NF-κB activity was assessed by dual- luciferase reporter assay and cytokine profiles were evaluated by ELISA and Cytometric Bead Array method.
Results showed that the activity of pNF-κB was higher in cells harboring TLR4 D299G compared to the other cells. However, the activity of pAKT, pERK1 and pIRAK was higher in wild-type. The results of cytokine measurements showed about four fold higher level of IL-8 in cells with wild-type TLR4.
This study suggest that TLR4 Asp299Gly gene variant has an impact on TLR4 signaling and potentially on intestinal homeostasis due to impaired control signals at the epithelial cell level which may lead to chronic intestinal inflammation and interrupted intestinal homeostasis and may eventually lead to colorectal cancer.
1. Alpay HC, Etem EO, Kaygusuz I, Yüce H, Karlidag T, Keles E, et al. Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris Nasus Larynx 2010; 37(1):29-32
2. Davoodi H, Seow HF. Variant Toll-Like Receptor4 (Asp299Gly and Thr399Ile Alleles) and Toll-Like Receptor2 (Arg753Gln and Arg677Trp Alleles) in Colorectal Cancer. Iran J Allergy Asthma Immunol 2011;10(2):91-9.
3. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85(2):85-95.
4. Bonaiuto C, McDonald PP, Rossi F, Cassatella MA.Activation of nuclear factor-κB by β-amyloid peptides and interferon-γ in murine microglia. J Neuroimmunol 1997; 77(1):51-6.
5. Cario E, Podolsky D. Intestinal epithelial tollerance versus in tollerance of commensals. Mol Immunol 2005;42(8):887-93.
6. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 2008; 14(5-6):346-52.
7. Schroder J, Schumann RR. Single Nucleotide Polymorphisms of Toll-Like Receptors and Susceptibility to Infectious Disease. Lancet infect Dis 2005; 5(3):156-64.
8. Sun J, Turner A, Xu J, Grönberg H, Isaacs W. Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol 2007; 25(3):250-9.
9. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G. The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem 2005; 51(11):2178-80.
10. Arbour NC, Lorenz E, Schutte BC, Zabner JJ, Kline N, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2):187-91.
11. Franchimont D, Vermeire S, El-Housni H, Pierik M, Van Steen K, Gustot TE, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 2004; 53(7):987-92.
12. Schmidt C. Immune system’s toll-like receptors have good opportunity for cancer treatment. J Natio Cancer Instit 2006; 98(9):574-5.
13. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram- negative septic shock. Arch Intern Med 2002; 162(9):1028-32.
14. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008; 68(11):4026-30.
15. Papadimitraki ED, Bertsias GK, Boumpas DT. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 2007; 29(4):310-8.
16. Savkovic DS, Koutsouris A, Hecht G. Activation of NF- κB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol Cell Physiol 1997; 273(4Pt 1):1160-7.
17. Hu J, Jacinto R, McCall C, Li L. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. J Immunol 2002; 168(8):3910-4.
18. Guha M, Mackman N. The phosphatidylinositol 3- kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem 2002;277(35):32124-32.
19. Bowling WM, Hafenrichter DG, Flye MW, Callery MP.Endotoxin tolerance alters phospholipase C-gamma 1 and phosphatidylinositol-3-kinase expression in peritoneal macrophages. J. Surg Res 1995; 58(6):592-8.
20. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR,Visintin A, Latz E, et al. LPS-TLR4 signaling toIRF-3/7 and NF-kappaB involves the toll adapters TRAM andTRIF. J Exp Med 2003; 198(7):1043-55.
21. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier- Hayes D, Redmond HP. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. Immunol 2003; 170(2):795-804.
22. He W, Liu Q, Wang L, Chen W, Li N, Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 2007; 44(111):2850-9.
23. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19(6):652-7.
24. Haller D, Bode C, Hammes WP, Pfeifer AMA, SchiVrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelialcell/leucocyte co-cultures. Gut 2000; 47(1):79-87.
| Files | ||
| Issue | Vol 11, No 2 (2012) | |
| Section | Articles | |
| Keywords | ||
| Colorectal cancer Polymorphism Toll like receptors | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
